跳至主要内容
临床试验/CTRI/2024/05/066965
CTRI/2024/05/066965尚未招募4 期

Efficacy, safety and economic analysis of topical preparations in patients with mild to moderate atopic dermatitis AD: a randomized open-labelled active controlled trial - NI

All India Institute of Medical Sciences, Jodhpur0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
4 期
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1.Non-immunocompromised males or females aged 2 years or older with a clinical diagnosis of mild to moderate Atopic Dermatitis
  • 2.An IGA of disease severity of at least mild to moderate at baseline (a score of 2 or 3)

排除标准

  • 1.Pigmented lesion(s) in any treatment area at baseline, which would interfere with evaluations
  • 2.History of any confounding skin conditions
  • 3.History or presence of HIV, diabetes, malignancy, serious active or recurrent infection, clinically significant severe renal insufficiency or severe hepatic disorders
  • 4.Use within 14 days of baseline of: 1) systemic antibiotics, 2) calcipotriene or other vitamin D preparations, or 3) retinoids or 4) study drugs
  • 5.Known allergy or hypersensitivity to study drugs

研究者

发起方
All India Institute of Medical Sciences, Jodhpur

相似试验